ArticleClinical and molecular hepatology2026

Reply to correspondence on "Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: nationwide cohort study with genetic risk analysis".

No numbers read from the abstract.

Not cited yet